4//SEC Filing
Peterson Kristine 4
Accession 0001062993-24-006046
CIK 0001177648other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:23 PM ET
Size
5.4 KB
Accession
0001062993-24-006046
Insider Transaction Report
Form 4
Peterson Kristine
Director
Transactions
- Award
Stock Option (right to buy)
2024-03-06+15,700→ 15,700 totalExercise: $15.66Exp: 2034-03-06→ Common Stock (15,700 underlying)
Footnotes (1)
- [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 6, 2024), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2025 annual meeting of stockholders.
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001508596
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:23 PM ET
- Size
- 5.4 KB